• Something wrong with this record ?

Preparation, biological activity and endogenous occurrence of N6-benzyladenosines

Dolezal K, Popa I, Hauserová E, Spíchal L, Chakrabarty K, Novák O, Krystof V, Voller J, Holub J, Strnad M.

. 2007 ; 15 (11) : 3737-3747.

Language English Country Great Britain

Cytokinin activity of forty-eight 6-benzyladenosine derivatives at both the receptor and cellular levels as well as their anticancer properties were compared in various in vitro assays. The compounds were prepared by the condensation of 6-chloropurine riboside with corresponding substituted benzylamines and characterized by standard collection of physico-chemical methods. The majority of synthesized derivatives exhibited high activity in all three of the cytokinin bioassays used (tobacco callus, wheat leaf senescence and Amaranthus bioassay). The highest activities were observed in the senescence bioassay. For several of the compounds tested, significant differences in activity were found between the bioassays used, indicating that diverse recognition systems may operate. This suggests that it may be possible to modulate particular cytokinin-dependent processes with specific compounds. In contrast to their high activity in bioassays, the tested compounds were recognized with only very low sensitivity in both Arabidopsis thaliana AHK3 and AHK4 receptor assays. The prepared derivatives were also investigated for their antiproliferative properties on cancer and normal cell lines. Several of them showed very strong cytotoxic activity against various cancer cell lines. On the other hand, they were not cytotoxic for normal murine fibroblast (NIH/3T3) cell line. This anticancer activity of cytokinin ribosides may be important, given that several of them occur as endogenous compounds in different organisms.

000      
00000naa 2200000 a 4500
001      
bmc10001230
003      
CZ-PrNML
005      
20111210155154.0
008      
100120s2007 xxk e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Doležal, Karel, $d 1967- $7 xx0100056
245    10
$a Preparation, biological activity and endogenous occurrence of N6-benzyladenosines / $c Dolezal K, Popa I, Hauserová E, Spíchal L, Chakrabarty K, Novák O, Krystof V, Voller J, Holub J, Strnad M.
314    __
$a Laboratory of Growth Regulators, Palacky University & Institute of Experimental Botany AS CR, Slechtitelů 11, 783 71 Olomouc, Czech Republic. dolezal@risc.upol.cz
520    9_
$a Cytokinin activity of forty-eight 6-benzyladenosine derivatives at both the receptor and cellular levels as well as their anticancer properties were compared in various in vitro assays. The compounds were prepared by the condensation of 6-chloropurine riboside with corresponding substituted benzylamines and characterized by standard collection of physico-chemical methods. The majority of synthesized derivatives exhibited high activity in all three of the cytokinin bioassays used (tobacco callus, wheat leaf senescence and Amaranthus bioassay). The highest activities were observed in the senescence bioassay. For several of the compounds tested, significant differences in activity were found between the bioassays used, indicating that diverse recognition systems may operate. This suggests that it may be possible to modulate particular cytokinin-dependent processes with specific compounds. In contrast to their high activity in bioassays, the tested compounds were recognized with only very low sensitivity in both Arabidopsis thaliana AHK3 and AHK4 receptor assays. The prepared derivatives were also investigated for their antiproliferative properties on cancer and normal cell lines. Several of them showed very strong cytotoxic activity against various cancer cell lines. On the other hand, they were not cytotoxic for normal murine fibroblast (NIH/3T3) cell line. This anticancer activity of cytokinin ribosides may be important, given that several of them occur as endogenous compounds in different organisms.
650    _2
$a financování organizované $7 D005381
650    _2
$a adenosin $x analogy a deriváty $x farmakologie $x chemie $7 D000241
650    _2
$a protinádorové látky $x farmakologie $x chemická syntéza $x chemie $7 D000970
650    _2
$a proteiny huseníčku $7 D029681
650    _2
$a biotest $7 D001681
650    _2
$a kultivované buňky $7 D002478
650    _2
$a cytokininy $x farmakologie $x chemická syntéza $x chemie $7 D003583
650    _2
$a fibroblasty $x účinky léků $7 D005347
650    _2
$a myši $7 D051379
650    _2
$a buňky NIH 3T3 $7 D041681
650    _2
$a rostliny $x účinky léků $7 D010944
650    _2
$a proteinkinasy $7 D011494
650    _2
$a receptory buněčného povrchu $7 D011956
650    _2
$a rostlinné buňky $7 D059828
700    1_
$a Popa, Igor $7 jo2012690165
700    1_
$a Hauserová, Eva, $d 1954- $7 jk01040194
700    1_
$a Spíchal, Lukáš $7 xx0123817
700    1_
$a Chakrabarty, Kuheli
700    1_
$a Novák, Ondřej $7 xx0120183
700    1_
$a Kryštof, Vladimír, $d 1973- $7 xx0097406
700    1_
$a Voller, Jiří. $7 _AN043406
700    1_
$a Holub, Jan $7 xx0100057
700    1_
$a Strnad, Miroslav, $d 1958- $7 jn20010309068
773    0_
$w MED00000769 $t Bioorganic & medicinal chemistry $g Roč. 15, č. 11 (2007), s. 3737-3747 $x 0968-0896
910    __
$a ABA008 $b x $y 8
990    __
$a 20090310084605 $b ABA008
991    __
$a 20111104085356 $b ABA008
999    __
$a ok $b bmc $g 707155 $s 569951
BAS    __
$a 3
BMC    __
$a 2007 $b 15 $c 11 $d 3737-3747 $i 0968-0896 $m Bioorganic & medicinal chemistry $x MED00000769 $n Bioorg Med Chem
LZP    __
$a 2010-b1/ipme

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...